» Articles » PMID: 22194606

Ras-related GTPases Rap1 and RhoA Collectively Induce the Phagocytosis of Serum-opsonized Zymosan Particles in Macrophages

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Dec 24
PMID 22194606
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Phagocytosis occurs primarily through two main processes in macrophages: the Fcγ receptor- and the integrin αMβ2-mediated processes. Complement C3bi-opsonized particles are known to be engulfed through integrin αMβ2-mediated process, which is regulated by RhoA GTPase. C3 toxin fused with Tat-peptide (Tat-C3 toxin), an inhibitor of the Rho GTPases, was shown to markedly inhibit the phagocytosis of serum (C3bi)-opsonized zymosans (SOZs). However, 8CPT-2Me-cAMP, an activator of exchange protein directly activated by cAMP (Epac, Rap1 guanine nucleotide exchange factor), restored the phagocytosis of the SOZs that was previously inhibited by the Tat-C3 toxin. In addition, a constitutively active form of Rap1 GTPase (CA-Rap1) also restored the phagocytosis that was previously reduced by a dominant negative form of RhoA GTPase (DN-RhoA). This suggests that Rap1 can replace the function of RhoA in the phagocytosis. Inversely, CA-RhoA rescued the phagocytosis that was suppressed by DN-Rap1. These findings suggest that both RhoA and Rap1 GTPases collectively regulate the phagocytosis of SOZs. In addition, filamentous actin was reduced by the Tat-C3 toxin, which was again restored by 8CPT-2Me-cAMP. Small interfering profilin suppressed the phagocytosis, suggesting that profilin is essential for the phagocytosis of SOZs. Furthermore, 8CPT-2Me-cAMP increased the co-immunoprecipitation of profilin with Rap1, whereas Tat-C3 toxin decreased that of profilin with RhoA. Co-immunoprecipitations of profilin with actin, Rap1, and RhoA GTPases were augmented in the presence of GTPγS rather than GDP. Therefore, we propose that both Rap1 and RhoA GTPases regulate the formation of filamentous actin through the interaction between actin and profilin, thereby collectively inducing the phagocytosis of SOZs in macrophages.

Citing Articles

RHOA Therapeutic Targeting in Hematological Cancers.

Santos J, Profitos-Peleja N, Sanchez-Vinces S, Roue G Cells. 2023; 12(3).

PMID: 36766776 PMC: 9914237. DOI: 10.3390/cells12030433.


SILAC-based quantitative proteomics to investigate the eicosanoid associated inflammatory response in activated macrophages.

Brace N, Megson I, Rossi A, Doherty M, Whitfield P J Inflamm (Lond). 2022; 19(1):12.

PMID: 36050729 PMC: 9438320. DOI: 10.1186/s12950-022-00309-8.


Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.

Jaganathan D, Bruscia E, Kopp B Int J Mol Sci. 2022; 23(14).

PMID: 35887098 PMC: 9319215. DOI: 10.3390/ijms23147750.


Profilin choreographs actin and microtubules in cells and cancer.

Pimm M, Hotaling J, Henty-Ridilla J Int Rev Cell Mol Biol. 2020; 355:155-204.

PMID: 32859370 PMC: 7461721. DOI: 10.1016/bs.ircmb.2020.05.005.


Profilin: many facets of a small protein.

Davey R, Moens P Biophys Rev. 2020; 12(4):827-849.

PMID: 32661903 PMC: 7429631. DOI: 10.1007/s12551-020-00723-3.


References
1.
Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

2.
Witke W . The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004; 14(8):461-9. DOI: 10.1016/j.tcb.2004.07.003. View

3.
Caron E, Self A, Hall A . The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inflammatory mediators. Curr Biol. 2000; 10(16):974-8. DOI: 10.1016/s0960-9822(00)00641-2. View

4.
Lafuente E, van Puijenbroek A, Krause M, Carman C, Freeman G, Berezovskaya A . RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell. 2004; 7(4):585-95. DOI: 10.1016/j.devcel.2004.07.021. View

5.
Pollard T, Borisy G . Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003; 112(4):453-65. DOI: 10.1016/s0092-8674(03)00120-x. View